The Patent Trial and Appeal Board (PTAB) is the administrative tribunal within the U.S. Patent and Trademark Office that adjudicates contested post-grant patent validity
The Supreme Court is poised to decide one of the most consequential questions in pharmaceutical patent law: when does a generic drug’s marketing create
On December 23, 2025, the U.S. Court of Appeals for the Federal Circuit affirmed three decisions of the Patent Trial and Appeal Board (“PTAB”)
On October 27, 2025, Judge Sidney H. Stein of the U.S. District Court for the Southern District of New York denied OpenAI’s motion to
On August 19, 2025, the Federal Circuit issued a non-precedential opinion affirming a Louisiana district court’s invalidation of U.S. Patent No. 6,918,801, owned by
On July 23, 2025, the U.S. Court of Appeals for the Federal Circuit denied a petition for both panel and en banc rehearing in
On June 26, 2025, the United States District Court for the Northern District of California issued a decision in LookSmart Group v. Google LLC,
On June 9, 2025, the U.S. Court of Appeals for the Federal Circuit issued a precedential opinion in Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung
Patent owners are granted a limited monopoly over their inventions, and with that monopoly comes a bundle of rights. These rights fall into two
Gregorini v. Apple, Inc., No. 2:20-cv-00406-SSS-JC, 2024 WL 5264949 (C.D. Cal. Nov. 25, 2024) For a plaintiff to allege copyright infringement, they must prove
Steuben Foods, Inc. v. Shibuya Hoppmann Corp., 127 F.4th 348 (Fed. Cir. 2025) In a recent decision, the Federal Circuit in Steuben Foods, Inc.
In a significant ruling, the Federal Circuit has clarified the status of patent applications in the realm of intellectual property law, asserting that a
